Search Results - "Meeusen, J. W."

Gastrointestinal hypomotility with loss of enteric nicotinic acetylcholine receptors: active immunization model in mice by Meeusen, J. W., Haselkorn, K. E., Fryer, J. P., Kryzer, T. J., Gibbons, S. J., Xiao, Y., Lennon, V. A.

“…Background  Autoimmune gastrointestinal dysmotility (AGID) is a limited form of dysautonomia. The only proven effector to date is IgG specific for ganglionic…”
Get full text

A-226 Validation of Calculated Glycerol Corrected Triglycerides by Scott, R, Meeusen, J W, Jaffe, A S, Vasile, V C, Donato, L J

“…Abstract Background Patients with elevated free glycerol can have falsely elevated triglyceride concentrations known as pseudohypertriglyceridemia. Most…”
Get full text

A-231 A modified Sampson LDL-C equation to improve concordance with the reference method at low levels of LDL-C by Sampson, M, Meeusen, J W, Donato, L J, Jaffe, A S, Remaley, A T

“…Abstract Background Patients at high risk for Atherosclerotic Cardiovascular Disease (ASCVD), who do not achieve adequate lowering of LDL-cholesterol (LDL-C)…”
Get full text

A-221 Evaluation of Apolipoprotein B Equivalent Low-density Lipoprotein Cholesterol Measurements by Hornseth, J M, Donato, L J, Jaffe, A S, Meeusen, J W

“…Abstract Background Low-density lipoprotein cholesterol (LDL-C) is the primary biomarker for assessing risk for atherosclerotic cardiovascular disease (ASCVD)…”
Get full text

A-203 An Equation based on the Standard Lipid Panel for Calculating Low-Density Lipoproteins-Triglycerides by Wolska, A, Sampson, M, Meeusen, J W, Donato, L J, Jaffe, A S, Remaley, A T

“…Abstract Background There is growing evidence that low-density lipoprotein-triglyceride (LDL-TG) may be a better biomarker to define atherosclerotic…”
Get full text

A-228 Evaluation of an Equation for Low-Density Lipoproteins-Triglycerides in Predicting ASCVD Risk in the UK Biobank Population by Wolska, A, Sampson, M, Zubiran, R, Meeusen, J W, Donato, L J, Jaffe, A S, Remaley, A T

“…Abstract Background Low-density lipoprotein-cholesterol (LDL-C) is the main univariate risk marker recommended for initial atherosclerotic cardiovascular…”
Get full text

A-210 Ldl-c to non-hdl-c ratio method: a simple way to determine bias for ldl-c methods on hypertriglyceridemic samples by Gcingca, T A, Sampson, M, Meeusen, J W, Donato, L J, Jaffe, A S, Remaley, A T

“…Abstract Background Beta-quantification (BQ) is the reference method for LDL-C but is not widely available. It is difficult, therefore, for clinical…”
Get full text

A-208 An Improved Formula for Predicting Low LDL-C Based on an Enhanced Sampson-NIH Equation by Coverdell, T C, Sampson, M, Meeusen, J W, Donato, L J, Jaffe, A S, Remaley, A T

“…Abstract Background Low-density lipoprotein cholesterol (LDL-C) is used to assess atherosclerotic cardiovascular disease (ASCVD) risk and to manage…”
Get full text

Impact of race-independent equations on estimating glomerular filtration rate for the assessment of kidney dysfunction in liver disease by Stämmler, Frank, Derain-Dubourg, Laurence, Lemoine, Sandrine, Meeusen, Jeffrey W, Dasari, Surendra, Lieske, John C, Robertson, Andrew, Schiffer, Eric

“…Altered hemodynamics in liver disease often results in overestimation of glomerular filtration rate (GFR) by creatinine-based GFR estimating (eGFR) equations…”
Get full text

Estimating Glomerular Filtration Rate from Serum Myo-Inositol, Valine, Creatinine and Cystatin C by Stämmler, Frank, Grassi, Marcello, Meeusen, Jeffrey W, Lieske, John C, Dasari, Surendra, Dubourg, Laurence, Lemoine, Sandrine, Ehrich, Jochen, Schiffer, Eric

“…Assessment of renal function relies on the estimation of the glomerular filtration rate (eGFR). Existing eGFR equations, usually based on serum levels of…”
Get full text